A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients ; day:24 ; month:4 ; year:2019 ; pages:1-11
Clinical pharmacokinetics ; (24.4.2019), 1-11
- Urheber
-
Smit, Cornelis
Wasmann, Roeland E.
Goulooze, Sebastiaan C.
Hazebroek, Eric J.
Dongen, Eric P. A. Van
Burgers, Desiree M. T.
Mouton, Johan W.
Brüggemann, Roger J. M.
Knibbe, Catherijne A. J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-019-00762-4
- URN
-
urn:nbn:de:101:1-2019051719100683505125
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smit, Cornelis
- Wasmann, Roeland E.
- Goulooze, Sebastiaan C.
- Hazebroek, Eric J.
- Dongen, Eric P. A. Van
- Burgers, Desiree M. T.
- Mouton, Johan W.
- Brüggemann, Roger J. M.
- Knibbe, Catherijne A. J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
Development of a dosing system for individualized therapy with oral films
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
Development of a dosing system for individualized therapy with oral films
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
Development of a dosing system for individualized therapy with oral films
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control